The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β
Gang Wang(Jiangsu University), Junnian Zheng(Xuzhou Medical College), Nan Huang(Sun Yat-sen University), Dafei Chai(Xuzhou Medical College), Liantao Li(Jiangsu University), Lulu Han(Weifang University), Juan Li(Shandong First Medical University), Dandan Xu(Jiangnan University), Wei Zheng(Kunming Institute of Botany), Xiaowan Zhou(Xuzhou Medical College), Yan-Fang Lv(Xuzhou Medical College), Huizhong Li(Jiangsu University), Zengli Guo(University of North Carolina at Chapel Hill)
Cited by 36
Related Papers
Translation and functional roles of circular RNAs in human cancer
|Molecular Cancer|2020|962
High-Throughput Synthesis of Single-Layer MoS<sub>2</sub> Nanosheets as a Near-Infrared Photothermal-Triggered Drug Delivery for Effective Cancer Therapy
|ACS Nano|2014|921
Ki67 is a promising molecular target in the diagnosis of cancer (Review)
|Molecular Medicine Reports|2014|859
A natural in situ fabrication method of functional bacterial cellulose using a microorganism
|Nature Communications|2019|232
An Analysis of the Expression and Association with Immune Cell Infiltration of the cGAS/STING Pathway in Pan-Cancer
|Molecular Therapy — Nucleic Acids|2018|211